Project Details
Description
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, efficacy, and pharmacokinetics of budesonide extended-release tablets administered once daily in pediatic subjects aged 5 to 17 years with active, mild to moderativ
| Status | Active |
|---|---|
| Effective start/end date | 1/29/24 → 2/28/34 |
Funding
- BAUSCH HEALTH US, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.